- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01049581
Effects of Pediatric Aquatic Therapy in Children With Spastic Cerebral Palsy
Aquatic intervention had been applied in children with neuromotor impairment for years, yet there has been little progress toward objective identifications of therapy goals, interventions, and outcomes. Thus, we attempt to design aquatic intervention activity for children with cerebral palsy to evaluate the effect of hydrotherapy.
Purpose:
To evaluate the effects of pediatric aquatic therapy on motor performance, daily activity and social participation in children with spastic cerebral palsy.
Method:
The study enrolled 27 children with spastic cerebral palsy aged from 4 to 12 years old.These children were dived into two groups: traditional rehabilitation therapy (control group), and hospital based pediatric aquatic therapy program. We evaluate the motor performance, daily activity and social participation before and after the intervention and compared the difference in improvement between groups. The measurements include modified Ashworth score, Gross Motor Function Measure (GMFM -66), Vineland Adaptive Behavior Scale (VABS) , and Cerebral Palsy Quality of Life Questionnaire for Children (CPQOL).
Expect effect:
We suppose pediatric aquatic therapy in spastic cerebral palsy children could improve motor function and daily activity.Children could improve self-esteem and we hypothesize this could improve social participation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
- We conducted a well-designed study to investigate the effectiveness of PAT on motor function, activities of daily living (ADL),and health related quality of life(HRQOL) perspectives for children with CP.
- A convenience sample of 27 children was recruited for the study from the outpatient clinics of the Department of Physical Medicine and Rehabilitation of two tertiary hospitals: Chang Gung Memorial Hospital and Taipei Veterans General Hospital.
- The study was designed as a single blinded, prospective, case control study.
- The pediatric aquatic therapy group got more improvementon motor performance measured by GMFM-66.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Taipei, Taïwan
- Chang Gung Memorial Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Children diagnosed as cerebral palsy, spastic type
- Gross Motor Functional Classification (GMFCS) level II-IV
- Age: 4-12 y/o
- Informed consent by parents
- Modified Ashworth score 2 or3
- If participant history of epilepsy ,well controlled by medication
Exclusion Criteria:
- History of psychiatric diseases
- Poor controlled epilepsy
- Received botox injection or surgery in recent three months
- Children diagnosed as attention deficit hyperactivity disorder(ADHD) or autism
- Severe mental retardation
- Active infection (Body temperature > 100°F)
- Communication problems
- Bowel incontinence
- Bladder incontinence
- Severe cardiovascular disease
- Infectious skin conditions and open wound
- Nasogastric tubes or gastrostomy tubes
- Colostomy ,urostomy or ileostomy bags
- Acute orthopedic injury with pain and instability
- Diabetes
- Chlorine sensitivity
- Latex allergies
- Tracheostomy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: pediatric aquatic therapy
The children of the PAT group participated in a 1 hour/time, twice-per-week, 12-week, PAT program in addition to conventional rehabilitation programs
|
two hours per week, one hour per time, total 12 weeks
Autres noms:
|
|
Aucune intervention: conventional therapy
The children included in the control group continued with their original rehabilitation programs
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Unit on Gross Motor Function Measure Scale (GMFM)
Délai: 3 months
|
The GMFM is a standardized observational instrument designed and validated to measure change in gross motor function over time in children with cerebral palsy.
The scoring key is meant to be a general guideline.
However, most of the items have specific descriptors for each score.
It is imperative that the guidelines contained in the manual be used for scoring each item.
The score ranges from 0 to 100 and the higher represent the better gross motor function in children with cerebral palsy
|
3 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Daily Living Subscale of Vineland Adaptive Behavior Scale
Délai: 3 months
|
Vineland Adaptive Behavior scale was developed by Sara et al at 1984 and was used to measure adaptive and maladaptive behavior in children age form 3-12 years-old.
The daily living subscale range from 0 to 198 and the higher the score represent the better captive behavior.
|
3 months
|
|
Subscale on Cerebral Palsy Quality of Life Questionnaire for Children
Délai: 3months
|
This questionnaire was developed for Children and was a condition-specific quality of life (QOL) questionnaire for children with cerebral palsy aged 4 to 12 years.
It contains social , functioning, participation , emotional ,access, pain and disability, and family health components.
Participation is the main component in this study.
This sub score ranges from 0 to 81 , higher scores represent better participation
|
3months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: ChiaLing Chen, Chang Gung Memorial Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Manifestations neurologiques
- Lésions cérébrales chroniques
- Maladies musculo-squelettiques
- Maladies musculaires
- Manifestations neuromusculaires
- Hypertonie musculaire
- Paralysie cérébrale
- Paralysie
- Spasticité musculaire
Autres numéros d'identification d'étude
- 981947B
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .